Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer

Sang‐A Kim(Seoul National University Bundang Hospital), Keun‐Wook Lee(Seoul National University Bundang Hospital)

Scientific Reports

December 10, 2021

10.1038/s41598-021-03197-9

Cited by 20

Related Papers

AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)

|The Oncologist|2023|19

Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With<i>PIK3CA</i>Mutations and Overcoming Strategies

|Anticancer Research|2025|1